Kapitales Research started its journey in September 2021 to offer its customers data-driven and authentic general financial advice. By the end of 2023, we introduced a plethora of products, expanding its reach and establishing a solid foothold in the Australian market:
2022 was a successful journey for us and we were able to support our clients in Australia in their investment journey. After a fruitful year, in 2023 we have launched 2 more products:
As we close another successful year, 2024 marks a year of growth, innovation, and expansion for Kapitales Research. It has been a journey fueled by our commitment to providing data-driven and authentic financial advice tailored to the evolving needs of our clients. Despite a challenging global landscape, this year has witnessed the launch of new products, remarkable performance in our key offerings, and impactful milestones that strengthened our position in the market.
In 2024, we demonstrated our agility and responsiveness to market needs by launching two flagship products:
The year 2024 was defined by significant global events that shaped the investment landscape. We provided stability and clarity to our clients during a time of uncertainty, helping them navigate these developments:
Product |
Sl No |
Ticker |
Company Name |
Recommendation date |
Recommendation Price |
Price as on 05 January 2025 |
% Growth |
Kapitales Research Daily Dose |
1 |
OCC |
Orthocell Ltd |
04-Jan-24 |
0.405 |
1.490 |
267.90% |
2 |
FND |
Findi Ltd |
25-Jan-24 |
1.200 |
4.700 |
291.67% |
|
3 |
ZIP |
Zip Co Ltd |
08-Feb-24 |
0.840 |
3.080 |
266.67% |
|
4 |
NXL |
Nuix Ltd |
21-Mar-24 |
2.170 |
6.240 |
187.56% |
|
5 |
LRV |
Larvotto Resources Ltd |
03-Jul-24 |
0.135 |
0.570 |
322.22% |
|
Kapitales Research Swing Trades |
1 |
CAT |
Catapult Group International Ltd |
24-Mar-24 |
1.475 |
3.560 |
141.36% |
2 |
CYL |
Catalyst Metals Ltd |
22-May-24 |
1.115 |
2.760 |
147.53% |
|
3 |
LRV |
Larvotto Resources Ltd |
03-Jul-24 |
0.130 |
0.570 |
338.46% |
|
4 |
AYA |
Artrya Ltd |
31-Jul-24 |
0.330 |
0.620 |
87.88% |
|
5 |
OCC |
Orthocell Ltd |
11-Sep-24 |
0.460 |
1.490 |
32.44% |
|
Kapitales Research Dividend Income |
1 |
MYR |
Myer Holdings Ltd |
18-Jan-24 |
0.670 |
1.220 |
82.09% |
2 |
WBC |
Westpac Banking Corp |
08-Feb-24 |
24.410 |
32.640 |
33.72% |
|
3 |
BEN |
Bendigo And Adelaide Bank Ltd |
28-Mar-24 |
10.250 |
13.150 |
28.29% |
|
4 |
AX1 |
Accent Group Ltd |
06-Jun-24 |
1.975 |
2.400 |
21.52% |
|
5 |
PRN |
Perenti Ltd |
26-Sep-24 |
1.075 |
1.430 |
33.02% |
|
Kapitales Research Small Cap Shooter |
1 |
SRG |
SRG Global Ltd |
20-Feb-24 |
0.765 |
1.370 |
79.08% |
2 |
WAF |
West African Resources Ltd |
05-Mar-24 |
1.010 |
1.490 |
46.80% |
|
3 |
BIO |
Biome Australia Ltd |
28-May-24 |
0.375 |
0.580 |
54.67% |
|
4 |
SDI |
SDI Ltd |
02-Jul-24 |
0.855 |
1.150 |
34.50% |
|
5 |
B4P |
Beforepay Group Ltd |
22-Oct-24 |
0.910 |
1.610 |
76.92% |
|
Kapitales Research Growth Equity Report |
1 |
SUN |
Suncorp Group Ltd |
26-Feb-24 |
15.680 |
19.550 |
24.68% |
2 |
PRU |
Perseus Mining Ltd |
25-Mar-24 |
2.065 |
2.630 |
27.36% |
|
3 |
ALQ |
ALS Limited |
22-Apr-24 |
13.400 |
15.210 |
13.51% |
|
4 |
ALL |
Aristocrat Leisure Ltd |
17-Jun-24 |
47.380 |
69.370 |
46.41% |
|
5 |
BRG |
Breville Group Ltd |
29-Jul-24 |
28.180 |
35.630 |
26.44% |
|
Kapitales Research Breakout Stocks Report |
1 |
TLX |
Telix Pharmaceuticals Ltd |
17-Jan-24 |
11.12 |
23.84 |
114.39% |
2 |
ZIP |
Zip Co Ltd |
22-Jan-24 |
0.740 |
3.080 |
316.22% |
|
3 |
EZZ |
EZZ Life Science Holdings Ltd |
08-Apr-24 |
0.735 |
3.030 |
312.24% |
|
4 |
LRV |
Larvotto Resources Ltd |
07-Aug-24 |
0.150 |
0.570 |
280.00% |
|
5 |
OCC |
Orthocell Ltd |
09-Sep-24 |
0.440 |
1.490 |
238.64% |
|
Kapitales Research Resource Report |
1 |
MAH |
Macmahon Holdings Ltd |
21-Feb-24 |
0.195 |
0.350 |
79.49% |
2 |
CMM |
Capricorn Metals Ltd |
28-Feb-24 |
4.800 |
6.470 |
34.79% |
|
3 |
TVN |
Tivan Ltd |
12-Jun-24 |
0.073 |
0.110 |
50.68% |
|
4 |
CYL |
Catalyst Metals Ltd |
10-Jul-24 |
1.410 |
2.760 |
95.74% |
|
5 |
DEG |
De Grey Mining Ltd |
18-Sep-24 |
1.255 |
1.820 |
45.02% |
|
Kapitales Research Renewable & Clean Energy Report |
1 |
ORG |
Origin Energy Ltd |
16-Feb-24 |
8.730 |
10.910 |
24.97% |
2 |
SVM |
Sovereign Metals Ltd |
31-May-24 |
0.650 |
0.770 |
18.46% |
|
3 |
VUL |
Vulcan Energy Resources Ltd |
26-Jul-24 |
4.440 |
5.450 |
22.75% |
|
4 |
AGL |
AGL Energy Ltd |
09-Aug-24 |
10.820 |
11.420 |
5.55% |
|
5 |
ARR |
American Rare Earths Ltd |
23-Aug-24 |
0.295 |
0.300 |
1.69% |
|
Kapitales Research Trending Trade Report |
1 |
CDA |
Codan Limited |
09-Jan-24 |
8.410 |
16.180 |
92.39% |
2 |
BOT |
Botanix Pharmaceuticals Ltd |
06-Feb-24 |
0.190 |
0.450 |
136.84% |
|
3 |
REG |
Regis Healthcare Ltd |
06-Feb-24 |
3.420 |
6.080 |
77.78% |
|
4 |
SXE |
Southern Cross Electrical Engineer Ltd |
20-Feb-24 |
0.930 |
1.500 |
61.29% |
|
5 |
OCC |
Orthocell Ltd |
10-Sep-24 |
0.460 |
1.490 |
223.91% |
|
Kapitales Research US Starter Report |
1 |
NYSE: TYL |
Tyler Technologies Inc |
15-Jan-24 |
US$429.00 |
US$584.17 |
36.17% |
2 |
NYSE: EDR |
Endeavor Group Holdings Inc. |
25-Mar-24 |
US$25.520 |
US$31.200 |
22.26% |
|
3 |
NYSE: FOXA |
Fox Corp |
27-May-24 |
US$33.61 |
US$49.32 |
46.74% |
|
4 |
NYSE: CRK |
Comstock Resources Inc. |
07-Oct-24 |
US$12.05 |
US$17.68 |
46.72% |
|
5 |
NASDAQ: TSLA |
Tesla Inc. |
28-Oct-24 |
US$269.19 |
US$410.44 |
52.47% |
|
Kapitales Research ASX 300 Report |
1 |
WGX |
Westgold Resources Inc. |
01-Feb-24 |
2.240 |
2.900 |
29.46% |
2 |
TLX |
Telix Pharmaceuticals Ltd |
21-Mar-24 |
13.270 |
23.840 |
79.65% |
|
3 |
CPU |
Computershare Ltd |
04-Apr-24 |
26.830 |
34.610 |
29.00% |
|
4 |
ANN |
Ansell Ltd |
11-Apr-24 |
26.660 |
34.030 |
27.64% |
|
5 |
PRN |
Perenti Ltd |
17-Oct-24 |
1.130 |
1.430 |
26.55% |
|
Kapitales Research Technology Report |
1 |
CAT |
Catapult Group International Ltd |
15-Jan-24 |
1.295 |
3.560 |
174.90% |
2 |
TNE |
TechnologyOne Ltd |
29-Jan-24 |
15.880 |
30.660 |
93.07% |
|
3 |
360 |
Life360 Inc. |
26-Feb-24 |
7.980 |
22.490 |
181.83% |
|
4 |
NXL |
Nuix Ltd |
20-May-24 |
2.980 |
6.240 |
109.40% |
|
5 |
BVS |
Bravura Solution Ltd |
16-Sep-24 |
1.360 |
2.260 |
66.16% |
|
KapitalesResearch Canadian Topnotch Report |
1 |
L |
Loblaw Companies Ltd |
19-Jan-24 |
CAD135.00 |
CAD191.50 |
41.86% |
2 |
CM |
Canadian Imperial Bank of Commerce |
23-Feb-24 |
CAD73.02 |
CAD90.63 |
43.67% |
|
3 |
AEM |
Agnico Eagle Mines Ltd |
08-Mar-24 |
CAD73.08 |
CAD117.14 |
60.29% |
|
4 |
ATZ |
AritziaInc |
14-Jun-24 |
CAD37.67 |
CAD57.60 |
52.91% |
|
5 |
WELL |
WELL Health Technologies Corp |
16-Aug-24 |
CAD4.75 |
CAD7.16 |
50.74% |
|
KapitalesResearch Emerging Market (India) Report |
1 |
DCAL |
DishmanCarbogenAmcis Ltd |
03-Jan-24 |
INR188.85 |
INR289.20 |
53.14% |
2 |
WOCKPHARMA |
Wockhardt Ltd |
14-Feb-24 |
INR451.55 |
INR1520.00 |
236.62% |
|
3 |
JUBLPHARMA |
Jubilant Pharmova Ltd |
17-Apr-24 |
INR671.80 |
INR1092.90 |
62.68% |
|
4 |
ABSLAMC |
Aditya Birla Sun Life Amc Ltd |
24-Apr-24 |
INR530.35 |
INR822.00 |
54.99% |
|
5 |
PRAJIND |
Praj Industries Ltd |
01-May-24 |
INR547.75 |
INR834.85 |
52.41% |
While delivering recommendation reports is at the heart of our business, we strive to create a holistic investment experience for our clients. Through timely market commentaries, flash news, and thematic articles, we kept our investors informed and engaged throughout the year.
As we step into 2025, we are excited to further expand our services into New Zealand and Canada, building on the success and trust we have established in Australian market. In New Zealand, we aim to launch tailored reports focusing on local industries and emerging investment opportunities, empowering investors with insights specific to their market. In Canada, we plan to strengthen our presence by introducing new thematic reports that delve into trending sectors, commodities, and ESG-focused investments, enhancing the value we offer to our Canadian clients.
Our commitment to innovation and investor empowerment remains unwavering. We will continue to enhance our product offerings, integrate cutting-edge technology like AI-driven analytics and virtual portfolio tools, and provide educational resources to guide investors at every step of their journey. With these initiatives, we are poised to support our clients in navigating the complexities of global markets and achieving success in the years ahead.
We thank our clients and partners for being an integral part of our journey and look forward to achieving greater heights together in the years to come.
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.